These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30059832)

  • 1. Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.
    Jiang Z; Liu Z; Li M; Chen C; Wang X
    Transl Oncol; 2018 Oct; 11(5):1171-1187. PubMed ID: 30059832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlate the
    Lyu H; Li M; Jiang Z; Liu Z; Wang X
    Comput Struct Biotechnol J; 2019; 17():1020-1030. PubMed ID: 31428295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer type-dependent correlations between TP53 mutations and antitumor immunity.
    Li L; Li M; Wang X
    DNA Repair (Amst); 2020 Apr; 88():102785. PubMed ID: 32007736
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Liu Z; Jiang Z; Gao Y; Wang L; Chen C; Wang X
    J Oncol; 2019; 2019():5952836. PubMed ID: 31275382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis.
    He Y; Wang X
    Ann Transl Med; 2020 Sep; 8(17):1050. PubMed ID: 33145269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients.
    Yao J; You Q; Zhang X; Zhang Y; Xu J; Zhao X; Li J; Wang X; Gong Z; Zhang D; Wang W
    Clin Genet; 2023 Feb; 103(2):200-208. PubMed ID: 36346122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin subcellular expression in wild-type and mutant
    Gurzu S; Jung I; Sugimura H; Stefan-van Staden RI; Yamada H; Natsume H; Iwashita Y; Szodorai R; Szederjesi J
    World J Gastrointest Oncol; 2020 Jul; 12(7):741-755. PubMed ID: 32864042
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Li L; Li M; Jiang Z; Wang X
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
    Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
    Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
    J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Predictive Value of
    Dong ZY; Zhong WZ; Zhang XC; Su J; Xie Z; Liu SY; Tu HY; Chen HJ; Sun YL; Zhou Q; Yang JJ; Yang XN; Lin JX; Yan HH; Zhai HR; Yan LX; Liao RQ; Wu SP; Wu YL
    Clin Cancer Res; 2017 Jun; 23(12):3012-3024. PubMed ID: 28039262
    [No Abstract]   [Full Text] [Related]  

  • 12. TP53 mutations, expression and interaction networks in human cancers.
    Wang X; Sun Q
    Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type.
    Koh J; Nam SK; Roh H; Kim J; Lee BC; Kim JW; Ahn SH; Park DJ; Kim HH; Park KU; Chung JH; Kim WH; Lee HS
    Genes Chromosomes Cancer; 2019 Jan; 58(1):12-22. PubMed ID: 30239046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
    Chen Y; Chen G; Li J; Huang YY; Li Y; Lin J; Chen LZ; Lu JP; Wang YQ; Wang CX; Pan LK; Xia XF; Yi X; Chen CB; Zheng XW; Guo ZQ; Pan JJ
    JAMA Netw Open; 2019 Sep; 2(9):e1911895. PubMed ID: 31539077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p53 in the progression of gastric cancer.
    Busuttil RA; Zapparoli GV; Haupt S; Fennell C; Wong SQ; Pang JM; Takeno EA; Mitchell C; Di Costanzo N; Fox S; Haupt Y; Dobrovic A; Boussioutas A
    Oncotarget; 2014 Dec; 5(23):12016-26. PubMed ID: 25427447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer.
    Assoun S; Theou-Anton N; Nguenang M; Cazes A; Danel C; Abbar B; Pluvy J; Gounant V; Khalil A; Namour C; Brosseau S; Zalcman G
    Lung Cancer; 2019 Jun; 132():65-71. PubMed ID: 31097096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-CpG sites preference in G:C > A:T transition of TP53 in gastric cancer of Eastern Europe (Poland, Romania and Hungary) compared to East Asian countries (China and Japan).
    Natsume H; Szczepaniak K; Yamada H; Iwashita Y; Gędek M; Šuto J; Ishino K; Kasajima R; Matsuda T; Manirakiza F; Nzitakera A; Wu Y; Xiao N; He Q; Guo W; Cai Z; Ohta T; Szekely T; Kadar Z; Sekiyama A; Oshima T; Yoshikawa T; Tsuburaya A; Kurono N; Wang Y; Miyagi Y; Gurzu S; Sugimura H
    Genes Environ; 2023 Jan; 45(1):1. PubMed ID: 36600315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.
    Tahara T; Shibata T; Okamoto Y; Yamazaki J; Kawamura T; Horiguchi N; Okubo M; Nakano N; Ishizuka T; Nagasaka M; Nakagawa Y; Ohmiya N
    Oncotarget; 2016 Jul; 7(27):42252-60. PubMed ID: 27323394
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Biton J; Mansuet-Lupo A; Pécuchet N; Alifano M; Ouakrim H; Arrondeau J; Boudou-Rouquette P; Goldwasser F; Leroy K; Goc J; Wislez M; Germain C; Laurent-Puig P; Dieu-Nosjean MC; Cremer I; Herbst R; Blons H; Damotte D
    Clin Cancer Res; 2018 Nov; 24(22):5710-5723. PubMed ID: 29764856
    [No Abstract]   [Full Text] [Related]  

  • 20. Bridging genomics and phenomics of gastric carcinoma.
    Cho J; Ahn S; Son DS; Kim NK; Lee KW; Kim S; Lee J; Park SH; Park JO; Kang WK; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim KM
    Int J Cancer; 2019 Nov; 145(9):2407-2417. PubMed ID: 30801717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.